Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Linopirdine analogue proves to be more potent neurotransmitter release enhancer

Oct. 21, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

MorphiDex NDA accepted for FDA review

Oct. 21, 1998

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Oct. 21, 1998

Phase I trial for Anergen multiple sclerosis compound demonstrates safety

Oct. 21, 1998

Yamanouchi introduces novel formulation of antiemetic drug

Oct. 20, 1998

First clinical findings presented for Lilly/Synaptic antimigraine drug

Oct. 20, 1998

Dopamine reuptake inhibitors in development at Pola for Parkinson's disease

Oct. 20, 1998

New AMPA and NMDA receptor antagonists in early research at RPR

Oct. 20, 1998

Neurotrophic/neuroprotective agents in development at Sanofi

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...